Alpha-mannosidosis market forecast sees steady growth through 2036

Sep 4, 2026 08:03 (49d ago)

Verifying

ResearchAndMarkets.com added an alpha-mannosidosis market forecast report to its offering.
2026 to 2036 forecasts cover seven major markets, including the United States and Japan.
LAMZEDE received U.S. approval in February 2023 for adult and pediatric patients.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.